Pixelgen Technologies is a VC-backed startup at the forefront of innovative life science research tools. Our technology, Molecular Pixelation (MPX), is used by our customers to enable spatial proteomics on single cells and gain new insights into cellular activity for applications such as drug development. The first product was launched in 2023 that targets the surface proteome of immune cells. The output of the wet-lab protocol is read on a NGS sequencer and analyzed by our computational tools. Pixelgen was founded in 2020 by serial entrepreneurs behind multiple innovative products and companies in the life sciences.